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INTRODUCTION
Rickettsial Diseases of Man
The rickettsial diseases of man can be
categorized into five groups:

(1) the typhus group,

including epidemic typhus and murine typhus; (2) the
spotted fever group, including American spotted
fevers, Boutonneuse fevers, Siberian tick typhus,
Queensland tick typhus, and rickettsialpox; (3)
tsutsugamushi disease; (4) trench fever; and (5) Q
fever.

With the exception of Q fever each disease is

transmitted to man by an arthropod vector; all have
an animal

rese~voir

(Philip 1966).

The three most important rickettsial diseases in
the United States are Rocky Mountain spotted fever,
murine typhus, and Q fever (Woodward 1973).

Much of

the field and laboratory work that has resulted in the
control of murine typhus was performed in the United
States where the disease is concentrated in the
southeastern states (White 1965b).
Murine TyPhus
Murine typhus is a serious but rarely fatal
febrile disease of worldwide distribution (Philip
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1966). Other names of the disease are: endemic
flea~borne

typhus (Benenson 1970); Tabardillo

(Mexico); shop typhus (Southeastern Asia); Manchurian
typhus; Toulon typhus; Moscow typhus; and red fever
of the Congo (Burrows 1968) .

The etiological agent

is Rickettsia typhi, formerly known as R. prowazeki
var. mooseri, R. muricola, and R. mooseri (Burrows

1968).
The reservoirs of murine typhus are typically
domestic rats (Rattus rattus and Rattus norvegicus)
and the vector is usually the oriental rat flea
(Xenopsylla cheopis).

Fleas acquire the rickettsiae

from the circulating blood of infected rats which
show no signs of illness.

The fleas remain infective

throughout their one year life span, transmitting the
rickettsiae to other rats and to man by feces.

The

classic mode of infection occurs when the flea takes
a blood meal from an infected rat.

The ectoparasite

defecates the rickettsiae, which contaminate the bite
site or any other fresh skin wounds.

Human infection

usually results from rubbing the flea feces into the
skin while scratching (Philip 1966, Benenson 1970).
Inhalation of dried infective flea feces can also be
a mode of transmission (Wisseman et al. 1962, Beneson

1970).
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The clinical features of murine typhus are
similar to but milder than those of epidemic louse-

borne typhus.

After an incubation period of six to

14 days, an individual has muscular pains, shivering,
loss of appetite, fever above 102° F, which lasts
approximately 14 days, and a macular rash which
appears on the trunk of the body at the end of the
first week.

Complications and fatalities rarely

occur (Philip 1966, Benenson 1970).
Immunity is conferred by one attack (Benenson
1970), and cross-immunity can occur in persons who
have had epidemic louse-borne typhus (Philip 1966).
Rickettsia tyPhi is closely antigenically related to
Rickettsia prowazeki, the etiological agent of the
more serious epidemic louse-borne typhus (Burrows
1968).

A vaccine against murine typhus has not been

developed because attenuated vaccines of R. prowazeki
(strain E) provide resistance to murine typhus
(Philip 1966).
Laboratory diagnosis of murine typhus as well
as other rickettsial diseases can be determined by
two methods:

(1) demonstration of rising antibody

titer in serial serum specimens and (2) insolation
and identification of the causative agent (Philip
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1966, Joseph 1970).
Statement of Problem and Objectives
Three decades ago murine typhus was considered
to be a serious public health problem in the United
States with the highest incidence of the disease
occurring in the southeastern states (Miller and
Beeson 1946, Pratt 1958, White 1965a, White 1965b).
The requirement for reporting cases of murine typhus
to local health authorities went into effect in
1920 (White 196Sb).
that year (Table 1).

A total of 31 cases was reported
The number of reported cases

reached a maximum of 5401 in 1944.

Following that

peak year a steady decline of reported cases has
occurred.

Approximately 35 murine typh·us cases per

year have been reported for the past 15 years.
Currently murine typhus is categorized as a notifiable
disease of low frequency by the Center for Disease
Control (1975).

Yet, the disease is still considered

to be widespread in nature (Adams et al. 1970).

The

most effective control measure for the vectors of
the disease is DDT (Philip 1966).
The purpose of this study is to examine the
nature and history of murine typhus .

Explanations

will be sought to account for the dramatic decrease
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in number of cases reported and for the continued
maintenance of the present low level of incidence in
.....

the United States.

-.
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HISTORICAL ASPECTS

Early Developments
Murine typhus was first described in the United
States in 1913 when six cases were reported in
Atlanta, Georgia (Paullin 1913).

Diagnosis of these

cases was based only on clinical findings.

Shortly

thereafter the disease appeared in North Carolina
and Texas (Miller and Beeson 1946).
In 1910 Brill (1910) described a typhus-like
disease occurring endemically in New York, New York.
In 1912 he observed a cross-immunity between this
disease and epidemic typhus (Anderson and Goldberger
1912).

Zinsser (1934) hypothesized that the disease

was a recrudescence of epidemic typhus.

Plotz (1943)

demonstrated the immunologic identity of Brill's
findings with epidemic typhus by using the complement
fixation test with rickettsial suspensions as
antigens.

For years murine typhus was erroneously

called Brill's disease in the southern states because
of the similar clinical features (Miller and Beeson
1946, White 1965b).

Brill's disease is currently

known as Brill-Zinsser disease (Joseph 1970).
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Maxcy's (1926) epidemiological studies in the
southeastern states indicated that murine typhus was
a milder disease· than epidemic typhus.

He found that

it occurred in the absence of body lice, the vector
of epidemic typhus, and that it occurred more commonly
in summer and fall as opposed to winter and spring,
when epidemic typhus appears.

He suggested that the

reservoir was a rat or mouse, as opposed to man which
is the reservoir for epidemic typhus, and that a
blood sucking parasite was the vector.
Maxcy's hypothesis was substantiated in 1931 by
the experimental work of two, independently operating
groups:

Dyer, Rumreich, and Badger in Baltimore,

Maryland, and Moeser, Castaneda, and Zinsser in
Mexico City, Mexico (Pratt 1958, White 1965b).

The

Baltimore group produced evidence that the oriental
rat flea (Xenopyslla cheopis) was the vector of the
disease (Dyer et al. 1931).

The Mexico City group

produced evidence that indicated that the domestic
rat was the reservoir (Moeser et al. 1931).

Since

then the disease has been known as murine typhus
(White 1965b).
The first specific serological test for murine
typhus was the complement fixation test developed
in 1941 (Bengston 1941).

Prior to this time the

8

non-specific Weil-Felix test had been used in both
experimental clinical work (White 1965b).
Control Programs In 1945, following a peak year in which 5401
cases of murine typhuswerereported, the United
States Public Health Service began the first
comprehensive typhus control program in nine states
in which murine typhus was highly endemic (White 1965a,
White 1965b).

This program involved expansion of rat

proofing of buildings, poisoning and trapping of rats,
and dusting of rat runs with DDT.

Subsequent

evaluations of rat poisoning and DDT dusting programs
indicated a significant reduction in the number of
fleas, mites, lice, typhus antibodies in rats, and
murine typhus cases reported (Morlan and Hines 1951,
Smith 1958).

Other factors, such as improved garbage

collection and disposal, increased reliance of private
industry on pest-control companies, intensified
sanitation programs, and the development of effective
anticoagulant rodenticides, also played a part in
reducing the incidence of the disease (White 1965a).
The USPHS control was terminated in 1952 following
a nearly 15-fold decrease in number of cases reported
(White 1956b).
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In contrast, a four-year epidemiological study
conducted by Fox and Garcia-Moll (1961) in San Juan,
Puerto Rico indicated a dramatic decrease in reported
cases as well as in rat flea populations in spite
of unsuccessful rat control measures, low level
sanitation practices in many areas, and the lack of
a DDT dusting program.

They also observed that as

mite ectoparasites increased, rat flea ectoparasites
decreased.

This decline in incidence still remains

an enigma which led to White's hypothesis (1965a)
that factors as yet unknown can affect the
epidemiological profile of murine typhus.
Nevertheless, the control of fleas by dusting rat runs
with DDT is considered by most workers to be the best
method of controlling murine typhus (Philip 1966).
However, all major uses of DDT in the United States
were banned by the Environmental Protection Agency
effective December 31, 1972 (Council of Environmental
Quality 1972).

Arthropod and rodent control

departments of the Florida Division of Health
currently use 2% heptachlor or 5% chlordane for
dusting rat runs for elimination of ectoparasites;
upon restriction of use of chlordane, 5% malathion
will probably be used; the anticoagulant, dicumoral,
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is used as a rodenticide (Whittaker pers. comm.).
Treatment
Coincidenta~

with the initiation of the USPHS

t yphus control program was the development of
chloramphenicol and tetracycline, broad-spectrum
antibiotics which proved to be highly effective in
treating rickettsial diseases (Ley and Smadel 1954,
Pratt 1958).

The first antibiotic to be clinically

used for rickettsial diseases was chloramphenicol
which ·was administered in La ·Paz, Bolivia in 1947
for treating of epidemic typhus (Payne et al. 1948).
Both chloramphenicol and tetracycline are
rickettsiostatic and the eventual recovery from the
disease is dependent upon the immune response of the
individual (Anigstein et al. 1948, Wong and Cox 1948,
Smadel et al_. 1949, Snyder et al. 1950).

The use of

broad-spectrum antibiotics has dramatically reduced
the prolonged febrile courses of rickettsial diseases
and the frequent deaths which resulted (Ley and Smadel

1954).
Current treatement for murine typhus is the same
as for epidemic typhus.

Administration of drugs of

the tetracyline group (Terramycin, Achromycin,
Aureomycin) or chloramphenicol (Chloromycetin) produce
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equally effective results.

Recommended dosage for

adults is an initial dose of 2 gm followed by 2 gm
daily in divided _doses.

Antibiotic treatment should

continue until at . least the lOth day after onset of
symptoms and for a minimum of 48 hours after the
fever has subsided (Philip 1966).
Current Diagnostic Methods
The complement fixation serologic test is the
most practical diagnostic method for differentiating
rickettsial groups (Joseph 1970).

However, for

within-group differentiation, such as between murine
typhus and epidemic typhus, species specific antigens
must be used.

These are prepared by removing soluble

group specific antigens from the rickettsial organisms
by repeated washing which leaves the firmly attached
species-specific antigens on the cell wall (Philip
1966).

Since this is a time consuming and expensive

procedure, most commercial complement fixation
preparations contain soluble group specific antigens
(Joseph 1970).
Complement fixing antibodies can be detected
about seven to nine days after onset.

A peak titer

occurs between the 12th and 16th days.

The titer

declines slowly during the following three to six

12
months and remains at a comparatively low level for
years.

Diagnosis is based on a four-fold or greater

rise in titer beeween acute and convalescent phase
serum specimens, or on a decline in titer between
paired sera taken at four to six weeks and 12 to ·l4
weeks after onset, or on a titer greater than 1:160
for a single convalescent phase serum sample.
Complement fixation antibodies occur in significant
titer for many years after rickettsial infection or
immunization (Joseph 1970).
Broad-spectrum antibiotics may partially or
completely inhibit complement fixation antibody
formation (Lynnette et al. 1952).

For this reason

considerable significance has been placed on the
Weil-Felix agglutination reaction, one of the
earliest devised serological tests for rickettsial
diseases (Sonnenwirth 1970).
Sonnenwirth (1970) discussed various aspects of
the Weil-Felix test.

Nonspecific antigens, designated

OX-19, OX-2, and OX-K of the 0 variant of nonmotile
strains of the bacterial species, Proteus vulgaris,
are agglutinated by antibodies produced as a result
of certain rickettsial diseases.

A fourfold rise in

titer is obtained for both murine and epidemic typhus
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with Proteus OX-19 antigens.

Variable rises in titer

are obtained for Rocky Mountain spotted fever with
Proteus OX-19

an~igens.

Murine typhus, epidemic

typhus and Rocky Mountain spotted fever can produce
less than fourfold rises in titer with Proteus OX-2
antigens, however the latter can also produce a
fourfold rise with this antigen.

Only tsutsugamushi

disease produces a positive reaction with Proteus
OX-K antigens.

Because of the similarities in rise

in Proteus OX-19 titers, the Weil-Felix test cannot
be used to differentiate between murine typhus,
epidemic typhus, and Rocky Mountain spotted fever.
Antibodies to Proteus OX-19 can be detected
during the second week of murine typhus.

Peak titers

of about 1:640 to 1:1280 occur late in the third
week of illness; the titer then declines rapidly
(Joseph 1970).

Presumptive diagnosis is based on a

fourfold or greater rise in titer between acute and
convalescent phase serum specimens; significance is
placed on a titer of 1:160 or greater in a single
serumsample (Sonnenwirth 1970).

Sonnenwirth (1970)

further stated that low titers showing little change
usually indicate past Proteus infections.
Isolation and identification of R. typhi can
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be accomplished by inoculating an adult male guinea
pig with blood taken from the patient during the
febril phase.

However, this method of diagnosis is

not routinely used in clinical laboratories.
Subpassage of peritoneal fluid, the tunica vaginalis,
and spleenic tissue results in increase in rickettsial
concentration.

This allows the rickettsiae to be

demonstrated in impression smears of the spleen and
testicular tissues (Joseph 1970).
Host reactions in infected male guinea pigs
have been used to differentiate between epidemic

typhus, murine typhus, and Rocky Mountain spotted
fever . . Murine typhus produces the characteristic
Neile-Mooser reaction.

This is an inflamatory

reaction of the tunica vaginalis which results in a
nonreducible scrotal swelling.

The inflamatory

exudate consists of Moeser cells which are large
mononuclear serosal cells filled with intracytoplasmic
rickettsiae.

Epidemic typhus rarely produces scrotal

swelling and does not produce Moeser cells.

Rocky

Mountain spotted fever produces reducible scrotal
swelling and large mononuclear cells with rickettsiae
visible in both the cytoplasm and nucleus (Philip

1966).
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Correlation Between Temperature and Prevalence
Hill and Morlan (1948) showed correlation between
the seasonal occurrence of murine typhus and the
seasonal prevalence of the oriental rat flea.

Stewart

and Hines (1954) observed a peak in cases reported in
the summer in rural areas, but an even distribution
of cases throughout the year in urban areas.

Smith

(1957) demonstrated a correlation between the monthly
abundance of the oriental rat flea and the monthly
incidence of murine typhus . antibodies found in a
sample of both species of domestic rats.

Mohr et

al. (1953) found that murine typhus was widespread
in rats in rural areas where the average January
temperature was 47° F or greater, but was not found
in rural areas where the average January temperature
was below 40

0

.

F even though the disease occurred

in rats in northern urban areas in heated buildings.
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INCIDENCE
WHO Statistics
Between 1969 and 1973 a total of 1309 cases of
typhus classified as either murine or endemic was
reported to the World Health Organization (Table 2).
During this five year period Israel reported 521
cases~

which constituted 39.8% of the worldwide

incidence; this is the equivalent of 17.966 cases per
100,000 population.

The Maltese Islands reported

107 cases (8.2% of the worldwide incidence) which is
equivalent to 33.334 cases per 100,000 population.
The United States reported 153 cases (11.7% of
worldwide incidence); the equivalent being .075 cases
per 100,000 population.

Since some reporting

countries did not specify the exact number of cases,
these data represent low extremes.
USPHS Statistics
During the past seven years 86.9% of the reported
cases in the United States came from the south
Atlantic, east south central, and west south central
areas (Table 3).
White (1965b).

This distribution was shown by
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During these years, 69.7% of the total cases occurred
in Texas.

In 1974, 26.9% of the reported cases came

from California. Inaccuracies in Reporting
It appears that the number of cases of murine
typhus reported to the USPHS does not reflect the
actual prevalence of the disease.
support this conclusion.
showed

th~t

Several studies

Hill and Ingraham (1947)

although only 61 cases were reported in

1943 in Coffee County, Alabama, 211 individuals
claimed to have had the disease.

Complement fixation

and/or Weil-Felix tests were positive for 135 of the
211 individuals.

This indicates that only 45 . 1% of

the actual cases of murine typhus were reported.

In

1945 complement fixation tests performed on 4219 food
handlers in San Antonio, Texas, proved positive for
3.5% (Davis and Pollard 1946) .

From this sample

they estimated that approximately 700 cases per year
occurred between 1935 and 1945; the highest reported
incidence was 91 cases in 1944.

A survey conducted

in four counties in southwestern Georgia revealed
that only about 33% of the cases which occurred in
1945 were reported to health authorities (Williams
1949).

Quinby and Shubert (1953) studied 351 reported
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and 99 unreported cases which occurred in eight
southern states between 1948 and 1951.

Only 58% of

the reported cases were positive for complement fixing
antibodies, and 33% of the unreported cases were
positive.
It appears that the United States prior to
and during the peak years of murine typhus incidence
the disease was under-reported and following the peak
years it was over-reported (Pratt 1958, Burrows 1968).
Burrows (1968) stated that over-reporting resulted
largely from misinterpretation of low-titer Weilfelix reactions.
Maltese Islands Epidemiological Profile
A murine typhus epidemiological profile somewhat
similar to that of the United States occurred on the
Maltese Islands.

Vasallo (1970) discussed incidence

between 1944 and 1967.
in 1944 (Table 4).

Sixty-five cases were reported

A maximum of 135 reported cases

occurred in 1945, followed by an abrupt decline to
35 cases in 1946.

Mini-peak years occurred in 1950

and 1955 with 57 and 30 cases reported, respectively.
A leveling off period, with an average of no greater
than 14 cases per year, occurred between 1956 and
1967.
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Vasallo (1970) suggested that the abrupt
appearance of murine typhus on the Maltese Islands
resulted from intToduction of the disease during
wartime conditions.

He believed that ships bearing

troops and cargo from North Africa were the probable
source of entry for rats bearing fleas infected with
murine typhus and bubonic plaque.

The presence of

bubonic plague emphasized the need for intensified
rodent control.

Debris was removed and liberal

amounts of DDT powder and anti-flea emulsion were
used.

Although Vasallo (1970) considered murine

typhus to be a minor contemporary health hazard on
the Maltese Islands, more recent WHO statistics
indicate that 1972 and 1973 were mini-peak years with
each having 32 reported cases (Tables 2 and 4).

These

islands, therefore, had the highest incidence of the
disease per 100,000 population in the world.
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CONTEMPORARY STUDIES
USAF Hospital, Viet Nam
A recent study of localized outbreaks of murine
typhus was made by Miller et al. (1974) at the 12th
USAF Hospital, Cam Ranh Bay, South Viet Nam from July

1968 through June 1969.

Fifty-eight male military

personnel were infected.

Diagnosis was based on a

greater than threefold rise in complement fixation
antibody titer observed in paired sera collected at
7 and 14 day intervals.

Weil-Felix OX-K, OX-19, and

OX-2 tests were also performed.

The OX-19 and

specific antibody titers were usually in close
agreement in degree of dilutional rise.

However, the

maximum rise in titers, which never occurred until at
least 14 days after onset of illness, varied greatly.
Miller et al. (1974) described a typical case
history.

An acutely ill patient was admitted to the

hospital after a four day illness characterized by
headache, muscular pains, chills, and fever.
Arthralgia, cough, chest pain, and nausea soon
developed.

A macular rash appeared over the abdomen

on the fith day and lasted four days.

Twice daily
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his temperature reached 104° F.

With the appearance

of the rash 500 mgm tetracycline was administered
every six hours. - Following the tetracycline therapy
his temperature became normal within 24 hours and all
symptoms disappeared within 48 hours.

The patient

returned to duty less than two weeks following the
onset of illness.

This

d~amatic

shortening of the

duration of illness was attributed to tetracycline
therapy.
Diagnostic Problems
Murine typhus can be difficult to diagnose.
Mellin et al. (1970) illustrated this point in the
case history of a merchant seaman who recently
arrived from Mexico, and was admitted on the 11th day
of illness to a hospital in Baltimore, Maryland.
initial diagnosis was urinary tract infection.

The
One

week letter the diagnosis was changed to an influenzatype disease.

Although many of the symptoms of murine

typhus were evident, with the exception of a skin
a rickettsial disease was not suspected until an
elevated Proteus OX-19 was observed.

A fourfold

complement fixation antibody titer rise led to the
confirmed diagnosis of murine typhus.

The patient

recovered after treatment of 2 gm tetracycline
daily for 10 days.

ras~
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Of 28 confirmed cases of murine typhus in Texas
in 1969, influenza was the initial diagnosis in 22
instances.

Weil-Felix tests were performed when the

disease continued in spite of antibiotic therapy.
Murine typhus was then considered and tetracycline
was prescribed in 21 cases.

Examination for rash was

not made until late in the course of illness.

The

cases were confirmed by complement fixation
convalescent titer of 1:64 or paired sera threefold
titer rise (Older 1970).
Miller et al. (1974) recommend

tetracycline

therapy when murine typhus is suspected in the areas
of known high incidence and whenever a fever remains
of unknown origin after 72 hours of careful
investigation.
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RESERVOIRS AND VECTORS
Other Reservoirs and Vectors
Murine typhus may be widely distributed in nature
(Adams et al. 1970).

Animals other than domestic rats

can serve as reservoir hosts (White

1~ 965b).

Some

apparently naturally infected animals having positive
sera for murine typhus are:

opossum, cottontail

rabbit, fox squirrel, house mouse, rice rat, cotton
mouse, old-field mouse, cotton rat, dog, skunk, and
blue jay (Morlan et al. 1950).
infected animals are:

Some laboratory

gray squirrel, swamp rabbit,

and chipmunk (Brigham 1938).
The Oriental rat flea (X. cheopis) is considered
to be the most important vector, both from rat to rat
and from rat to man, however, the tropical rat mite
(Ornithomyssus bacoti), the rat louse (Polyplax
spinulosus), and the flea (Nosopsylla fasciatus) are
thought to spread the disease from rat to rat (Philip
1966).

Reiss-Gutfreund (1966) isolated R. typhi from

Hyalomma ticks removed from cattle in Ethiopia and
from body lice (Pediculus humanus humanus) from two
hospitalized cases of unspecified typhus in the same
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country.

Laboratory infection of

~-

humanus humanus

with!· typhi has been demonstrated (Philip 1966).
Adams et al .. -(1970) suggested tht opossums and
their ectoparasites are responsible for sporadic
outbreaks of murine typhus in Los Angeles and Orange
Counties, California.

Three cases of the disease

occurred in these adjacent counties in 1967.

An

epidemiological survey revealed that the three
individuals lived in association with dogs and cats,
and that opossums occurred in the immediate
environment.

Field specimens were collected over a

four month period during spring and summer of that
year.

Ectoparasite surveys showed that although

Rattus rattus and R. norvegicus were present,
Xenopsylla cheopis did not occur in this foothill area
The predominant

ectoparasite on dogs, cats, and

opossums was the cat flea (Ctenocephalides felis).
None of the 104 R. rattus and R. norvegicus captured
were serologically positive for R. typhi antibodies,
however, eight of 75 opossums (Didelphis marsupialis)
and one of seven skunks (Mephitis mephitis) had low
titers of 1:8 to 1:32.

R. typhi was isolated from

the spleen of one opossum.

The predominant

ectoparasite on opossums was C. felis and on skunks
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was a louse (Pulex simulans).
Over the previous 20 years there had been a
shift in the distribution of murine typhus cases from
urban Los Angeles areas where R. norvegicus was known
to

be sero-positive for R. typhi to the suburban

foothill areas of Los Angeles and Orange Counties.
Adams et al. (1970) suggested that a transmission
cycle other than the classic rat-flea one exists.
They implicated C. felis as the vector from animal
to animal and animal to man.
Older (1970) also thought C. felis was a vector
of murine typhus.

During 1969, 28 confirmed cases

of murine typhus were reported in Texas.
these led to an epidemiological study.

Twelve of
Ten of these

cases implicated C. felis as the vector.

Two of these

10 implicated opossums as reservoirs; two implicated
grass fleas, probably C. felis as the vector with
reservoir unknown; and, six suggested domestic cats
as reservoirs.

Older (1970) assumed that cat fleas

acquired R. typhi from infected rats.

~vo

cases studied suggested contact with cats.

of the
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DISCUSSION
Since murine typhus is considered an enzootic
disease in numerous naturally occurring animals
(Morlan et al. ' 1970) and since DDT, the most effective
ectoparasite control measure has been banned, it is
remarkable that so few cases are reported in the
United States.

A possible explanation for the low

number of reported cases is misdiagnosis due to
failure to recognize the signs and symptoms of the
disease.
White (1965b) observed that the infection rate
for whites is about eight times greater than for
blacks.

Of 126 cases of murine typhus studied by

Miller and Beeson (1946), rash was observed on 90% of
the 58 white individuals and on only 43% of the 68
Negros.
of murine

A possible
typh~s

exp~anation

for the low incidence

reported in blacks is that the rash

may be more difficult to detect.
Older (1970) stated that of the 28 cases of
murine typhus reported in Texas in 1969, rash was
observed on only 25%.

However, in these cases

examination for rash often was not performed until
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late in the course of illness.

Because influenza was

the erroneous original diagnosis in 78% of the cases,
he recommends that_ murine typhus be a part of the
differential diagnosis when symptoms of influenza are
present.
In the one case history described by Mellin et
al. (1970) no skin rash was observed even after
careful repeated examination.

Because of this and

because of the rarity of murine typhus in the United
States the ailment was initially diagnosed as a
urinary tract infection.

One week later, the

diagnosis changed to an influenza-type illness.
Consequently, they recommend that physicians be alert
to the pos$ibility of a murine typhus diagnosis.
A rash was observed on only 38% of the 58

patients studied by Miller et al. (1974).

All

patients were subjected to a battery of diagnostic
procedures, including Weil-Felix and complement
fixation tests.

Therefore, it is assumed that the

initial diagnosis in each case was murine typhus.
Tetracycline was administered to 57% of the
individuals upon laboratory diagnosis or strong
clinical evidence.

Neither the number of tetracycline

treated patients having a rash nor the complement
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fixation titers of tetracycline treated cases were
given.
The widespread use of tetracycline is another
possible explanation for the low number of murine
typhus cases reported.

This highly effective, broad-

spectrum antibiotic is currently a drug of choice,
second only to penicillin in the treatment of syphilis
by various county health departments of the Florida
Division of Health; it is administered in the same
dosage as prescribed for murine typhus (Abel pers.
comm.).

Nationwide, tetracycline has been among the

50 most prescribed drugs since 1966, ranking fourth
in 1973 and sixth in 1974 (Pharmacy Times 1975).
Older (1970) suggested tht tetracycline may have
been administered to cases of murine typhus which were
misdiagnosed as influenza.

Since the initial signs

and symptoms of murine typhus are similar to some
common ailments for which tetracycline is prescribed,
the disease could be treated properly, although
misdiagnosed, and never reported to health authorities.
Also, early administration of tetracycline or other
rickettsiostatic antibiotics

could obscure the

clinical signs and symptoms.
Available evidence does not indicate whether the
absence

of rash results from antibiotic therapy,
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failure to detect apparent clinical signs, or a
phenomenon of the disease process.
In an effort-to ascertain if cases of murine
typhus had gone undetected, Adams et al. (1970)
performed complement fixation tests . on 306 persons
who lived in endemic areas and who had recorded
histories of febrile illness.
negative for murine typhus.

All cases proved to be
Although this sampling

tends to indicate that missed cases are rare, no
statement was made if the 306 cases received
antibiotic therapy.

Lynnette et al. (1952) claimed

that broad-spectrum antibiotics may· partially or
completely inhibit complement fixation antibody
formation.
Inaccuracies in USPHS murine typhus

statistic~

(Davis and Pollard 1946, Hill and Ingraham 1947,
Williams 1949, Quinby and Shubert 1953) blemishes the
epidemiological profile.

·Several factors could have

contributed to the inaccuracies.

Of major importance

is that the complement . fixation test, the first
specific one for murine typhus detection was not
developed until 1941 (Beng~ton 1941).

Prior to this

time diagnosis was based on clinical findings or the
non-specific Weil-Felix test.

All confirmed diagnoses .
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were based on the Weil-Felix test (Miller and Beeson
1946).

Presently, confirmed diagnosis is based on a

group specific

co~lement

fixation test (Joseph 1970).

Another factor contributing to inaccuracies is
the use of different standards for determining a
positive identification.

The current bases for a

confirmed diagnosis are a fourfold rise in complement
fixation titer in paired sera and/or a 1:160 titer for
convalescent phase serum (Joseph 1970).

Cases

reported by the Texas State Health Department are
confirmed by a threefold rise in titer or a 1:64
convalescent phase titer (Older 1970).
Another factor affecting statistics is failure
to report murine typhus to health authorities
(Williams 1949).

This could result from failure of

a patient to see a physician while ill or from failure
of the attending physician to notify proper
authorities.
Of considerable interest are the WHO statistics ·
on incidence of murine typhus in Israel and the
Maltese Islands between 1969 and 1973 (Table 5).

In

1972 Israel reported 187 cases, the equivalent of
6.45 cases per 100,000 population; in 1972 and also in
1973 Malta reported 32 cases, the equivalent of 9.97
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cases per 100,000 population.

These figures exceed

the 4.00 cases per 100,000 population reported in the
United States in the peak year of 1944.

However, 90%

of the 5401 cases reported in the United States in
1944 were concentrated in the southeastern states
(White 1965b).

Therefore a density greater than

statistically recorded existed.
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SUMMARY
Murine typhus is a serious but rarely fatal
febrile disease.

The classic mode of transmission is

to man from rat reservoirs via rat flea vectors.

The

disease was first described in the United States
where much of the subsequent research has been done.
During the 1930's and 1940's murine typhus was
a significant public health problem in the
southeastern states.

The rapid decrease in reported

cases correlates with the initiation of the USPHS
typhus control program, which included the use of
insecticides, and with the
spectrum antibiotics.

~evelopment

of broad-

At present, murine typhus is

considered to be a worldwide disease of low frequency.
In the United States, it continues to be concentrated
in the southeastern area.
Possible explanations for the low frequency of
reported cases are misdiagnoses coupled with the
widespread use of tetracycline.

Many of the clinical

signs and symptoms of murine typhus are quite similar
to those of influenza-like

dise~se

tetracycline is often prescribed.

for which
Clinical
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misdiagnosis, which may occur when the classic rash
of the disease is not apparent, can be avoided by
confirming diagnosis with the complement fixation
serological test.
The late development of the complement fixation
test, almost 30 years after the diseas·e was first
described, was a major contributing factor to the
inaccuracies incorporated into the USPHS murine typhus
statistics.

Other factors contributing to a faulty

epidemiological profile are the use of different
standards for determining positive indentification and
the failure in reporting the disease.
The current status of murine typhus in the United
States is that of a relatively insignificant disease.
USPHS control measures, development of
rickettsiostatic antibiotics, and improved
insecticides and rodenticides have dramatically
reduced the incidence of the disease.
control measures should not be relaxed.

However,
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TABLE 1.

Year

Cases

Murine t:£Ehus in the United States a

Year

Cases

Year

Cases

1920

31

1938

2294

1956

98

1921

143 .

1939

2996

1957

114

1922

48

1940

1878

1958

71

1923

65

1941

2784

1959

51

1924

130

1942

3736

1960

68

1925

154

1943

4528

1961

46

1926

160

1944

5401

1962

32

1927

199

1945

5193

1963

35

1928

196

1946

3365

1964

30

1929

239

1947

2050

1965

;28

1930

511

1948

1171

1966

33

1931

333

1949

985

1967

52

1932

957

1950

685

1968

36

1933

2070

1951

378

1969

36

1934

1374

1952

205

1970

27

1935

1287

1953

221

1971

23

1936

1733

1954

163

1972

18

1937

2394

1955

135

1973

32

1974

26

aFrom White 1965b and Center for Disease Control 1968-1974.
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Worldwide reported cases ~ murine tvphus•

TABLE 2.

Cases/

1969

1970

1971

1972

1973

Total

100,000

'

popu1ationb

*

0.026

•

0.029

Africa
0

ltenya

3

Madagascar

1

+

21

55

68

25

30

0

+

19

14

3

1

0

1

+

159

10

1

0

Americas
Columbia
Costa Rica
. Ecuador
Guatemala
Mexico
Puerto Rico
. USA

199
34d

27

6

203d
1

23

27

*

18

Venezuela

32

153

1

1

0.930
1.889

0.066

4

2d

+

15.2

*
15.5

*
11.7

*

0.039

0.400
0.036
0.075
0.009

Asia
Israel

85

108

80

187

61

521

Malaysia

13

18

13

0

0

44

7

8

4

2

4

25

5

+

10

17

16

.1

1

+

Singapore

39.8

*
*

17.966
0.407
1.238

Oceania
Australia

*

0.048

8.2

33.334

Europe
Maltese Island!l
Portugal

32

32

3d

*

0 .031.

1

1

*

0.016

181

1309

Switzerland
358

To~al

aFrom World Health

252

208

Organ~zation

310

107

1971, 1972, 1974.

bPopulation data from National Geographic Society 1970.
csymbols:

+ = positive incidence, total number of cases not given;

- = not reporting;

* = negligible,

less than 5%.

dLow extreme.
eConflict with Center for Disease Control.
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'fABLE 3.

Distribution

States by

1968

2!

murine

1969

t~hus ~

1970

1971

!,!!

1972

~

United States a

1973

1974

Total

Reqions
Middle Atlantic
1

New York

1

East North Central
3

3

Michigan

1

l

:tllinois
West North Central
South Dakota

1

1

1

3

3

6

South ; ..tlantic
Maryland

1

Virqinia

3

1

2

2

West Virginia

1

l

South Caz:olina
Georqia

l

Florida

4

1
l

1

7

1

East South Central
Kentucky

1

1

l

l

Alabama
Mississippi

1

1

Tennessee

2

l

1

4

1

5

West South Central
Arkansas

l

l

1

1

1

Louisianna

l

1

Oklahoma
Texas

l

23

29

16

17

13

28

12

138

Pacific
Washington

l

1

Oregon

1

1

California

l

Hawaii

4

Total

36

36

27

1
3

23

a From Center for Disease Control 1968-1974.

18

32

7

9

2

9

26

198

38

TABLE 4.

Year

Murine typhu~ reported ~ Maltese Islandsa

Cases

Year

Cases

Year

Cases

1944

65

1954

22

1964

12

1945

135

1955

30

1965

17

1946

35

1956

16

1966

10

1947

27

1957

11

1967

12

1948

17

1958

22

1968

*

1949

25

1959

9

1969

10

1950

57

1960

12

1970

17

1951

44

1961

12

1971

16

1952

22

1962

12

1972

32

1953

10

1963

16

1973

32

1974

28

~rom Vasallo 1970 and World Health Organization 1971, 1972, 1974.

* Data

not available.

0.026

3.115

2.931

populationb

100,000

27

17

108

Cases

0.013

5.296

3.724

population

100,000

Cases/

1970

23

16

80

· Cases

bpo

lation data from Nation 1 Geographic Society 1970.

0.011

4.984

2.759

population

100,000

Cases/

1971

18

32

187

Cases

0.009

9.969

6.448

population

100,000

Cases/

1972

32

32

61

Cases

Murine typhus in Israel, Maltese Islands and United Statesa

From World Health Orqanization 1971, 1972, 1973.

States

United

53

10

Maltese

Islands

85

Israel

Cases

Cases/

1969

TABLE 5.

0.016

9.969

2.103

population

100,000

Cases/

1973

40
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